Back to search
federal
501(c)(3) required
HealthDevelopment of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
National Institutes of Health
Funding amount
Varies
Deadline
Jan 7, 2028
Geography
National (all U.S.)
Analyzing this grant for you…
About this grant
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Eligibility
See opportunity page for eligibility details.
Required documents
- SF-424
- Project narrative
- Budget
Eligible organization types
Nonprofit
Always verify grant requirements directly with the funder before applying.